DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately six "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

01 Jul 2013

Genzymes sclerosemiddel på vej til godkendelse

Genzyme har modtaget en positiv tilkendegivelse fra komiteen for medicinske produkter til brug for mennesker (CHMP) vedrørende LEMTRADA™ (alemtuzumab) i Europa.

Komiteen anbefaler, at LEMTRADA bliver godkendt til behandling af patienter med aktiv recidiverende remitterende multiple sclerose.

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2013 Danskbiotek. All rights reserved.